Navigation Links
Start Licensing, Inc. Welcomes FDA's Finding of Safety of Food From Cloned Animals
Date:1/16/2008

AUSTIN, Texas, Jan. 16 /PRNewswire-USNewswire/ -- Start Licensing, Inc. ("Start"), a joint venture of Geron Corporation (Nasdaq:) and Exeter Life Sciences supports the final risk assessment released by the US Food and Drug Administration on January 15. The assessment concluded that meat and dairy products from animal clones and their offspring are safe for human consumption.

"FDA's conclusion is consistent with a report released January 11, 2008 by the European Food Safety Authority and studies in other countries. These findings open the door to widespread adoption of the technology platform to enhance the quality of meat and dairy products" said Jonathan Thatcher, president of Start. "With this safety conclusion, ranchers and livestock producers can look to cloning technology to rapidly increase the best genetics, including quality and health traits, in their herds."

Created in 2005, Start is a joint venture of Geron Corporation (Nasdaq: GERN) and Exeter Life Sciences, Inc. Start manages and licenses a worldwide portfolio of intellectual property rights related to animal reproductive technologies, including foundational nuclear transfer cloning technology developed at the Roslin Institute. The nuclear transfer patents managed by Start have been upheld by the US PTO in three separate patent interference proceedings and in opposition proceedings by patent offices in other countries. Start's licensees are engaged in research and product development in food production, medical applications and other fields.

For more information call Natalie Garrett, Start Licensing/Turner Strategies, 202-466-9633


'/>"/>
SOURCE Start Licensing, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Elekta Announces Clinical Start-up of Elekta Synergy(R) S at UPMC
2. Visiprise Manufacturing Wins START-IT Top 50 Technologies Award
3. Actress Aida Turturro Tells Americans to Start Now to Talk With Their Healthcare Provider About Taking Control of Their Diabetes
4. Optherion, Inc. Completes $37 Million Start Up Financing
5. Medicsight Welcomes U.S. Initiative to Reimburse CT Colonography for Early Detection of Colorectal Cancer
6. Arius announces new findings in Trop-2 and CD59 CANCER antibody programs
7. Clinical Study Findings Show Safety and Procedure Success for TopSpin IntraVascular MRI Catheter for the Coronary Arteries
8. SALVAT has Completed Patient Enrollment in a Dose Finding Phase II Trial of SVT-40776 for the Treatment of Overactive Bladder
9. Topline Findings from Comparative Analysis of INVEGA(TM) and Quetiapine in Schizophrenia to be Postered at the 20th Annual U.S. Psychiatric and Mental Health Congress
10. Industry Executives Finding Value in Shift of Scientific Publications
11. New Study Findings Confirm CLEXANE(R)/LOVENOX(R) Long-Term Clinical Benefit in Patients Suffering From Acute Coronary Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... - OncoQuest Inc. ("OncoQuest"), a biopharmaceutical company focused ... for the treatment of cancer, today announced that ... Program with Cytovance Biologics ( Oklahoma City, ... product. Supported by recent positive interim clinical results ... cancer patients, OncoQuest has engaged Cytovance to establish ...
(Date:12/7/2016)... 2016  Vyriad Inc. announced today the appointment of ... of Directors. "We are delighted to welcome ... and develop our oncolytic viruses as the next generation ... Russell , MD, PhD, CEO of Vyriad. "Al and ... and passion for making a difference for cancer patients—their ...
(Date:12/7/2016)... ... December 07, 2016 , ... Cambrian ... for industrial facilities, today announced that one of the nation’s fastest growing craft ... novel water-energy purchase agreement (WEPA). Under the WEPA, a first for the industrial ...
(Date:12/6/2016)... -- The American Botanical Council (ABC) recognizes wellness ... Arnica montana ) through ABC,s Adopt-an-Herb program. This ... database, a comprehensive, interactive online tool that provides ... on the uses and health effects of more ... wellness company with healing arts centers, skin and ...
Breaking Biology Technology:
(Date:11/30/2016)... Poland , Nov. 30, 2016 Not many of us realize that ... aspects of recovery so we need to do it well. Inadequate sleep levels have ... high blood pressure, stroke, diabetes, and even cancer. Maybe now is the ... present that could help them to manage their sleep quality? ... ...
(Date:11/29/2016)... 29, 2016 BioDirection, a privately held medical ... the objective detection of concussion and other traumatic brain ... completed a meeting with the U.S. Food and Drug ... Pre-Submission Package. During the meeting company representatives reviewed plans ... precursor to commencement of a planned pilot trial. ...
(Date:11/29/2016)... CANNES, France , November 29, 2016 Nearly ... Continue Reading ... ... System is part of an efficient Identity Management. (PRNewsFoto/DERMALOG Identification Systems) ... DERMALOG is Germany's largest Multi-Biometric ...
Breaking Biology News(10 mins):